共 50 条
NHC-Ir(I) complexes derived from 5,6-dinitrobenzimidazole. Synthesis, characterization and preliminary evaluation of their in vitro anticancer activity
被引:18
|作者:
Sanchez-Mora, Arturo
[1
]
Valdes, Hugo
[1
]
Teresa Ramirez-Apan, Maria
[1
]
Nieto-Camacho, Antonio
[1
]
Hernandez-Ortega, Simon
[1
]
Canseco-Gonzalez, Daniel
[2
]
Morales-Morale, David
[1
]
机构:
[1] Univ Nacl Autonoma Mexico, Inst Quim, Ciudad Univ, Ciudad De Mexico 04510, Mexico
[2] Univ Autonoma Chapingo, CONACYT Lab Nacl Invest & Serv Agroalimentario &, Texcoco De Mora, Mexico
关键词:
Cancer;
Cytotoxic activity;
N-heterocyclic carbene;
Iridium complexes;
Fluorinated complexes;
Antioxidant properties;
HETEROCYCLIC CARBENE COMPLEXES;
IRIDIUM(III) COMPLEXES;
RUTHENIUM(II) COMPLEXES;
NATURAL-PRODUCTS;
METAL-COMPLEXES;
CANCER-CELLS;
GOLD(I);
AGENTS;
LIGANDS;
RHODIUM(I);
D O I:
10.1016/j.ica.2019.119061
中图分类号:
O61 [无机化学];
学科分类号:
070301 ;
081704 ;
摘要:
The design, synthesis, characterization and in vitro anticancer activity of a series of Ir(I) NHC complexes derived from 5,6-dinitrobenzimidazole is reported. The evaluation was performed in five human cancer cell-lines, namely glioblastoma (U-251), prostatic adenocarcinoma (PC-3), colorectal adenocarcinoma (HCT-15), mammary adenocarcinoma (MCF-7) and lung adenocarcinoma (SKLU-7), including healthy cells of African green monkey kidney (COS-7) for comparative purposes. The complexes exhibited better activity in comparison with the corresponding NHC ligand precursors. In particular, complex (4a) exhibited a good performance against PC-3 and SKLU-1 with IC50 values of 10.6 +/- 0.9 mu M and 10.4 +/- 1.5 mu M, respectively.
引用
收藏
页数:8
相关论文